ArticleCurrent oncology (Toronto, Ont.)2023

Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion.

Che-Jui Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.